Overview
Neurode Therapeutics develops small-molecule compounds targeting synaptic plasticity pathways to treat treatment-resistant depression and anxiety disorders.
More in Neuropharmaceuticals
Latest industry news
You Cannot Blind a Brain-Computer Interface Trial, and That Changes Everything for Clinical Science
2026-11-16 ยท Research
Implanted BCIs Restore Expressive Communication for Paralyzed Clinical Trial Participants
2026-11-15 ยท Research
Synchron Halts BCI Trials After Device Falls Short of Performance Benchmarks
2026-11-14 ยท Industry
China's Brain-Computer Interface Sector Enters Clinical Reality With First Commercial Implants
2026-11-13 ยท Industry
Company details
Category
๐ Neuropharmaceuticals
Location
Boston, MA
Funding
Series A โ $22M
Website
neurode-tx.comListed
2026-11-16
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ